1

INTRODUCTION

Patients often come to me asking:

• “Should I do ESG or a sleeve?”
• “Is ESG safer?”
• “Is the sleeve more effective?”
• “How do I know which one is right for me?”

These are excellent questions — and the truth is that both procedures are powerful, but they are designed for different patients, different goals, and different metabolic needs.

This article breaks down the differences clearly, honestly, and scientifically so you can understand which option aligns with your biology, your goals, and your longterm success.

‍

1. What Is ESG (Endoscopic Sleeve Gastroplasty)?

A nonsurgical, incisionless procedure.

ESG uses an endoscope (a flexible camera) inserted through the mouth to place internal sutures that reduce the stomach’s volume by about 60–70%.

Key features:

• No incisions
• No external scars
• No removal of stomach tissue
• Outpatient procedure
• Faster recovery
• Lower risk profile

How it works metabolically:

• Reduces stomach volume
• Slows gastric emptying
• Enhances early satiety
• Mild increase in GLP1
• Mild reduction in ghrelin

ESG is a restrictive + hormonal procedure, but with a milder metabolic effect than surgical options.

‍

2. What Is Sleeve Gastrectomy (VSG)?

A surgical procedure with powerful metabolic effects.

The sleeve removes ~75–80% of the stomach, including the fundus — the area that produces most of the hunger hormone ghrelin.

Key features:

• Minimally invasive laparoscopic surgery
• Permanent anatomical change
• Strong hormonal impact
• Strong metabolic improvement
• Stronger weightloss durability

How it works metabolically:

• Dramatic reduction in ghrelin
• Significant increase in GLP1 and PYY
• Improved insulin sensitivity
• Reduced inflammation
• Faster metabolic improvement

The sleeve is a restrictive + powerful hormonal procedure.

‍

3. WeightLoss Comparison: ESG vs. Sleeve

ESG:

• 15–20% total body weight loss
• Best for patients with lower BMI or early metabolic disease
• Weight loss is slower and more gradual

Sleeve:

• 25–30% total body weight loss
• Best for patients with higher BMI or significant metabolic disease
• Faster and more powerful weight loss

In simple terms:

• ESG = moderate weight loss
• Sleeve = strong weight loss

Both are effective — but not equally powerful.

‍

4. Metabolic Impact: ESG vs. Sleeve

ESG metabolic effect:

• Mild GLP1 increase
• Mild ghrelin reduction
• Mild insulin sensitivity improvement
• Good appetite control
• Good satiety

Sleeve metabolic effect:

• Dramatic ghrelin suppression
• Strong GLP1 and PYY increase
• Significant insulin sensitivity improvement
• Strong appetite suppression
• Strong satiety
• Strong antidiabetic effect

In simple terms:

• ESG = metabolic improvement
• Sleeve = metabolic transformation

If metabolic disease is a major concern, the sleeve is usually the better tool.

‍

5. Safety Profile: ESG vs. Sleeve

ESG safety:

• Very low complication rate
• No incisions
• No leaks
• No stapling
• No removal of tissue
• Quick recovery (2–3 days)

Sleeve safety:

• Very safe in experienced hands
• Small risk of leak
• Small risk of bleeding
• Recovery 1–2 weeks

In simple terms:

• ESG = lowest risk
• Sleeve = low risk, but higher than ESG

If a patient wants the safest possible option with the least downtime, ESG is ideal.

‍

6. Reflux: ESG vs. Sleeve

ESG and reflux:

• Does not typically worsen reflux
• May improve reflux in some patients

Sleeve and reflux:

• Can worsen reflux
• Can cause new reflux
• Not ideal for patients with severe GERD

In simple terms:

• ESG = refluxfriendly
• Sleeve = refluxsensitive

If reflux is a major issue, ESG or gastric bypass may be better choices.

‍

7. Durability: ESG vs. Sleeve

ESG durability:

• Good durability
• Some patients may need touchups
• Sutures can loosen over time
• Weight regain is possible

Sleeve durability:

• Strong longterm durability
• Sleeve can stretch slightly over years
• Weight regain possible but less common

In simple terms:

• ESG = durable but may need reinforcement
• Sleeve = more durable longterm

‍

8. Who Is a Good Candidate for ESG?

ESG is ideal for:

• BMI 30–40
• Patients wanting a nonsurgical option
• Patients wanting lower risk
• Patients wanting faster recovery
• Patients with mild metabolic disease
• Patients with reflux
• Patients not ready for surgery
• Patients who want a reversible option

ESG is a great “first step” for many patients.

‍

9. Who Is a Good Candidate for Sleeve?

Sleeve is ideal for:

• BMI > 40
• BMI 35–40 with metabolic disease
• Patients needing stronger weight loss
• Patients needing stronger metabolic improvement
• Patients without severe reflux
• Patients ready for surgery
• Patients wanting longterm durability

The sleeve is a powerful tool for patients who need more than restriction.

‍

10. ESG vs. Sleeve: My Decision Framework

When I help patients choose, I look at:

1. BMI

• 30–40 → ESG
• 40+ → Sleeve

2. Reflux

• Severe → ESG or bypass
• Mild → Either
• None → Either

3. Diabetes

• Mild → ESG or sleeve
• Moderate/severe → Sleeve

4. Weightloss goals

• Moderate → ESG
• Strong → Sleeve

5. Risk tolerance

• Lowest risk → ESG
• Accepts surgical risk → Sleeve

6. Recovery time

• Needs fast recovery → ESG
• Can take 1–2 weeks → Sleeve

7. Longterm durability

• Wants maximum durability → Sleeve
• Comfortable with potential touchups → ESG

There is no “onesizefitsall” answer — only the right answer for your biology and goals.

‍

CONCLUSION

ESG and sleeve gastrectomy are both excellent tools — but they are designed for different patients and different metabolic needs.

Choose ESG if you want:

• A nonsurgical option
• Lower risk
• Faster recovery
• Moderate weight loss
• A reversible procedure
• A refluxfriendly option

Choose Sleeve if you want:

• Stronger weight loss
• Stronger metabolic improvement
• Longterm durability
• A permanent solution
• A powerful hormonal effect

The right procedure is the one that matches your biology, your goals, and your longterm vision for your health.